Towards Healthcare
AI in Cardiology Market Envisioned at USD 20.35 Billion by 2032

AI in Cardiology Market Envisioned at USD 20.35 Billion by 2032

Status: Published Category: Healthcare IT Insight Code: 5077 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global AI in Cardiology Market Assessment

  • Overview
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others
  • Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America AI in Cardiology Market Assessment

  • Overview
  • North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Europe AI in Cardiology Market Assessment

  • Overview
  • Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Asia-Pacific AI in Cardiology Market Assessment

  • Overview
  • Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Latin America AI in Cardiology Market Assessment

  • Overview
  • Latin America  AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Latin America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Middle East & Africa (MEA) AI in Cardiology Market Assessment

  • Overview
  • Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Services
  • Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiac Arrhythmias
    • Stroke
    • Ischemic Heart Disease/CAD
    • Others

Company Profiles

  • Philips
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Siemens Healthineers
  • Medtronic Johnson & Johnson
  • Google Health
  • Microsoft Healthcare
  • Ultromics Limited
  • CardiAl I
  • IBM Watson Health
  • IDOVEN

Conclusion & Recommendations

  • Insight Code: 5077
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: December 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of experience specializing in the healthcare sector. His expertise spans various facets of healthcare, including market dynamics, emerging trends, regulatory changes, and technology-driven innovations. With a keen eye for detail and a deep understanding of the global healthcare landscape, Rohan has been instrumental in shaping actionable insights that guide healthcare organizations in making informed, data-driven decisions.

Rohan's extensive experience covers a wide range of healthcare segments, from pharmaceuticals and biotechnology to medical devices and digital health. He has worked on numerous projects that evaluate market potential, assess competitive landscapes, and identify growth opportunities in rapidly evolving sectors in the healthcare industry.

His analytical acumen and ability to synthesize complex data have made him a trusted advisor to healthcare companies, helping them navigate the challenges and opportunities within the healthcare ecosystem. Rohan is particularly passionate about how technology and innovation are reshaping healthcare delivery, and his reports provide valuable insights into the impact of digital transformation on patient care, outcomes, and cost-efficiency.

With a strong track record in healthcare market research, Rohan continues to contribute significantly to the advancement of the industry by delivering data-backed strategies and comprehensive market analysis.

FAQ's

The rising prevalence of cardiovascular diseases, including CAD, IHD, and strokes, has indeed led to an increased demand for AI detection methods in cardiology, driving market growth. AI technologies offer promising advancements in early diagnosis and personalized treatment planning for cardiovascular conditions. Continuous advancements in machine learning algorithms, data analytics, and imaging technologies contribute to more accurate and efficient cardiovascular disease detection and management. This innovation-driven progress enhances the overall effectiveness of AI applications in cardiology.

The North America dominate globally is expected to see a 41 percent increase in heart disease related medical costs between 2010 and 2040, from USD 126.2 billion to USD 177.5 billion. Some of the factors driving this upward trend include the regions expanding number of new artificial intelligence product approvals by regulators, a strong healthcare system and the rapid adoption of cutting edge products.

Key market players, including Philips, Siemens Healthineers, Medtronic, Johnson & Johnson, Google Health, Microsoft Healthcare, Ultromics Limited, CardiAl, IBM Watson Health, and IDOVEN, are key market players contributing significantly to the growth of AI in cardiology. Their research, development, and integration of AI technologies in diagnostic tools and healthcare systems play a pivotal role in advancing cardiological practices.

World Health Organisation, Food and Drug Administration, National Institute of Health, European Parliamentary Research Service, American College of Cardiology Foundation, British Heart Foundation, Center for Disease Control and Prevension.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515